Amgen to buy ChemoCentryx for $3.7B
Amgen was having a relatively quiet year on the mergers and acquisitions front, at least until Aug. 4, when the Thousand Oaks-based biotech firm announced it will purchase ChemoCentryx for nearly $3.7 billion. ChemoCentryx is a Silicon Valley biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. It has Read More →
Ventura, Santa Barbara County ag revenues both grew 5% in 2021
Both Santa Barbara and Ventura counties saw total agriculture revenue rise 5% between 2020 and 2021, combining for nearly $4 billion in revenue, despite a steep decline in a usually popular fruit, avocados. The 2021 crop reports for both Santa Barbara County and Ventura County were released in late July, while the county of San Read More →
Arcutis to raise $150M in public stock offering
Arcutis Biotherapeutics, a Westlake Village-based company developing drugs for immune dermatological conditions, plans to raise $150 million through a public offering of additional shares of common stock. Arcutis announced the pricing of those shares on Aug. 2, at $20 per share. Shares of Arcutis closed at $19.50 that day and then shot up 17% on Read More →
Semtech announces $1.2B Sierra Wireless acquisition
Semtech Corporation, a Camarillo-based semiconductor company specializing in Internet of Things applications, is making its largest acquisition ever, announcing Aug. 2 that it will buy Sierra Wireless for $1.2 billion. Based in Vancouver, Canada, Sierra Wireless also makes components for Internet of Things applications. “Internet of Things” refers to devices connected to the internet that Read More →
Semtech in talks to buy Sierra Wireless for $1.2B
The Camarillo-based semiconductor company Semtech Corp. disclosed Aug. 2 that it “has engaged in advanced discussions” regarding a possible $1.2 billion acquisition of Sierra Wireless, a Canadian company that makes components for the Internet of Things applications that Semtech also specializes in. Bloomberg first reported a potential deal on Aug. 1, and that day shares Read More →
LTC shares up after report of rising earnings for Q2
Westlake Village-based real estate investment trust LTC Properties reported net income of nearly $55 million, or $1.36 per diluted share, for the second quarter ended June 30. That was up from $18.1 million, or 46 cents per diluted share, for the same period last year. Funds from operations attributable to common stockholders were $25.3 million Read More →
Cure sells $20M in intellectual property, replaces CEO and CFO
Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, will be selling a portion of its intellectual property and related assets for $20 million, the company announced July 28. The buyer was a company called TF Tech Ventures, and the deal closed July 22, Cure said in a July 28 filing with the Read More →
